Format

Send to

Choose Destination
Neurosurgery. 2014 Mar;74(3):310-9; discussion 319-20. doi: 10.1227/NEU.0000000000000267.

5-Aminolevulinic acid-derived tumor fluorescence: the diagnostic accuracy of visible fluorescence qualities as corroborated by spectrometry and histology and postoperative imaging.

Author information

1
*Department of Neurosurgery, University of Münster, Münster, Germany; ‡Department of Neurosurgery, Ludwig-Maximilians-University Munich, Klinikum Grosshadern, Munich, Germany; §Asklepios Klinik Nord Heidberg, Hamburg, Germany; ¶Department of Neurosurgery, University Regensburg Medical Center, Regensburg, Germany; ‖Laser-Research Laboratory, LIFE-Center at University Hospital of Munich, Munich, Germany; #Department of Clinical Radiology, Universitätsklinikum Münster, Münster, Germany; **Department of Neuropathology, Universtitätsklinikum Bonn, University of Bonn Medical Center, Bonn, Germany; ‡‡Medac, Gesellschaft für klinische Spezialpräparate mbH, Wedel, Germany.

Abstract

BACKGROUND:

5-Aminolevulinic acid is used for fluorescence-guided resections. During resection, different macroscopic fluorescence qualities ("strong," "weak") can be distinguished that help guide resections.

OBJECTIVE:

This prospective study was designed to assess the reliability of visible fluorescence qualities by spectrometry, pathology, and imaging.

METHODS:

Thirty-three patients with malignant gliomas received 5-aminolevulinic acid (20 mg/kg). After debulking surgery, standardized biopsies were obtained from tissues with "weak" and "strong" fluorescence and from nonfluorescing near and distant brain for blinded assessment of cell density and tissue type (necrosis, solid or infiltrating tumor, normal tissue). The positive predictive value was calculated. Unresected fluorescing tissue was navigated for blinded correlation to postoperative magnetic resonance imaging (MRI). Receiver operating characteristic curves were generated for assessing the classification efficiency of spectrometry.

RESULTS:

"Strong" fluorescence corresponded to greater spectrometric fluorescence, solidly proliferating tumor, and high cell densities, whereas "weak" fluorescence corresponded to lower spectrometric fluorescence, infiltrating tumor, and medium cell densities. The positive predictive value was 100% in strongly fluorescing tissue and 95% in weakly fluorescing tissue. Spectrometric fluorescence was detected in marginal tissue without macroscopic fluorescence. Depending on the threshold, spectrometry displayed greater sensitivity but lower specificity (accuracy 88.4%). Residual MRI enhancement in the tumor bed was detected in 15 of 23 (65%) patients with residual fluorescence, but in none of the patients without residual fluorescence.

CONCLUSION:

Macroscopic fluorescence qualities predict solid and infiltrating tumor, providing useful information during resection. Fluorescence appears superior to contrast enhancement on MRI for indicating residual tumor. Spectrometry, on the other hand, is more sensitive but less specific, depending on threshold definition.

ABBREVIATIONS:

5-ALA, 5-aminolevulinic acidCI, confidence intervalgamma-GT, gamma-glutamyl transpeptidaseGBM, glioblastoma multiformeNPV, negative predictive valuePPIX, protoporphyrin IXPPV, positive predictive valueSD, standard deviationWHO, World Health Organization.

PMID:
24335821
PMCID:
PMC4206350
DOI:
10.1227/NEU.0000000000000267
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center